Fluconazole does not directly cause bacterial vaginosis. It’s an antifungal, so it targets yeast rather than bacteria. However, a small percentage of women do develop BV shortly after antifungal treatment, and there are a few reasons why these two conditions can appear back-to-back in ways that feel connected.
What the Research Actually Shows
In a study of 142 women treated with oral antifungals for recurrent yeast infections, about 8% of women who were BV-negative at the start of treatment developed bacterial vaginosis within a week. After one month, 7% still had it. That’s a relatively small number, but if you’re one of them, the timing naturally makes you suspect the medication.
The same study found something interesting on the flip side: among women who already had both a yeast infection and BV at the start of treatment (about 6% of the group), antifungal therapy appeared to have a beneficial effect on the BV as well. The researchers concluded that antifungal treatment doesn’t prevent BV from showing up in women who didn’t already have it, but it also doesn’t seem to be the thing triggering it.
Why BV Can Show Up After Treatment
A yeast infection and BV share a common underlying condition: a disrupted vaginal microbiome. When the balance of bacteria in the vagina shifts away from the protective species that keep pH low (around 3.8 to 4.5), it creates an opening for either yeast overgrowth or BV-associated bacteria to take hold. Sometimes both are brewing at the same time, and treating one simply unmasks the other.
During fluconazole maintenance treatment, vaginal pH actually drops to healthier levels (around 4.5, compared to 4.7 or 4.8 during active yeast infection), and protective bacterial populations tend to improve. So the medication itself is nudging the environment in a favorable direction. But if your microbiome was already shifting toward BV before you started fluconazole, clearing the yeast won’t fix that separate problem.
There’s also a subtler mechanism at play. Some women, particularly those with recurrent yeast infections, have vaginal microbiomes dominated by a bacterial species called Lactobacillus iners rather than more protective strains. L. iners is less effective at keeping vaginal pH low and has been associated with a higher risk of developing BV. Women in this group had average vaginal pH readings around 5.0, which is above the normal range and closer to the territory where BV thrives. This isn’t something fluconazole causes. It’s a pre-existing pattern that makes both yeast infections and BV more likely.
Misdiagnosis Plays a Role Too
Another reason people connect fluconazole with BV is simpler: some women who take fluconazole for a suspected yeast infection never actually had a yeast infection in the first place. Studies on self-diagnosis accuracy have found that about 8% of women who believe they have a yeast infection are wrong. If you had BV all along and treated it with an antifungal, the symptoms wouldn’t improve, and it would look like fluconazole “caused” or “led to” BV when the real issue was a missed diagnosis.
The two conditions share some overlapping symptoms, particularly unusual discharge, but they differ in important ways. Yeast infections produce thick, white, cottage cheese-like discharge and tend to cause significant itching. BV typically causes thin, gray or yellowish discharge with a noticeable fishy odor, and usually doesn’t involve itching or burning. If your symptoms don’t match the classic yeast infection pattern, or if they persist after a full course of fluconazole, BV is worth considering.
What to Do if BV Follows a Yeast Infection
If you develop BV symptoms after fluconazole treatment, it requires a different type of medication. Antifungals don’t treat bacterial infections, and antibiotics don’t treat yeast. The two conditions need separate, targeted approaches.
For women who cycle between yeast infections and BV repeatedly, there is evidence that combination suppressive therapy can help. A regimen using both an antibiotic and fluconazole together on a monthly basis has been studied and shown to reduce BV recurrence while supporting healthier vaginal bacterial populations. This kind of dual approach targets the underlying instability rather than chasing one infection at a time.
Probiotics have also been studied as a way to support vaginal health alongside antifungal treatment. While fluconazole alone remains more effective at clearing active yeast infections, combining it with probiotics appears to reduce recurrence and improve symptoms. Strains like L. crispatus, L. acidophilus, and L. plantarum are among the most commonly studied for vaginal health. The evidence is promising but still developing, and results vary depending on the specific strain and delivery method.
The core takeaway: fluconazole isn’t causing your BV. But if your vaginal microbiome is already unstable enough to produce yeast infections, it may also be unstable enough to tip toward BV. Addressing that underlying imbalance, rather than just treating each infection as it comes, is what breaks the cycle.